Publications in collaboration with researchers from Universidad de Cantabria (20)

2023

  1. Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

2019

  1. Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics

    Translational Psychiatry, Vol. 9, Núm. 1

  2. Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 92-105

2018

  1. Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders

    Biochemical Pharmacology, Vol. 157, pp. 258-265

  2. The endocannabinoid system in mental disorders: Evidence from human brain studies

    Biochemical Pharmacology, Vol. 157, pp. 97-107

2017

  1. Chronic citalopram administration desensitizes prefrontal cortex but not somatodendritic α2-adrenoceptors in rat brain

    Neuropharmacology, Vol. 114, pp. 114

2015

  1. The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects

    Addiction Biology, Vol. 20, Núm. 4, pp. 773-783

2012

  1. Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function

    Journal of Biological Chemistry, Vol. 287, Núm. 53, pp. 44301-44319

2010

  1. α2-adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims

    Biological Psychiatry, Vol. 68, Núm. 9, pp. 869-872

2009

  1. Functional autoradiography and gene expression analysis applied to the characterization of the α2-adrenergic system in the chicken brain

    Journal of Chemical Neuroanatomy, Vol. 38, Núm. 4, pp. 282-291

2008

  1. COMPARISON OF GENE EXPRESSION PATTERNS IN CEREBRAL CORTEX BETWEEN THREE DIFFERENT ANIMAL MODELS OF DEPRESSION

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

  2. Gene expression patterns in brain cortex of three different animal models of depression

    Genes, Brain and Behavior, Vol. 7, Núm. 6, pp. 649-658

  3. Muscarinic receptor changes in the gerbil thalamus during aging

    Brain Research, Vol. 1243, pp. 38-46

2006

  1. Cannabinoid system in the budgerigar brain

    Brain Research, Vol. 1087, Núm. 1, pp. 105-113

2000

  1. Autoradiography of receptor-activated G-proteins in post mortem human brain

    Neuroscience, Vol. 96, Núm. 1, pp. 169-180

1998

  1. Selective increase of α(2A)-adrenoceptor agonist binding sites in brains of depressed suicide victims

    Journal of Neurochemistry, Vol. 70, Núm. 3, pp. 1114-1123

1996

  1. 2-Adrenoceptor subtypes in the human brain: A pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections

    European Journal of Pharmacology, Vol. 310, Núm. 1, pp. 83-93

  2. The subtype-selective α2-adrenoceptor antagonists BRL 44408 and ARC 239 also recognize 5-HT(1A) receptors in the rat brain

    European Journal of Pharmacology, Vol. 312, Núm. 3, pp. 385-388

1994

  1. Autoradiographic demonstration of increased α2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims

    Journal of Neurochemistry, Vol. 63, Núm. 1, pp. 256-265

1988

  1. α2-Adrenoceptors in human forebrain: autoradiographic visualization and biochemical parameters using the agonist [3H]UK-14304

    Brain Research, Vol. 475, Núm. 2, pp. 361-365